drugset / Trial / NCT01824056
The Differential Diagnosis of Parkinson's Disease and Parkinsonism by Positron-emission Tomography
Phase 2
Completed
120 enrolled
Chang Gung Memorial Hospital
National Science and Technology Council, Taiwan · collab
NaSingle-groupOpen-labelDiagnostic
Summary
The objective of this protocol is to analyze the sensitivity and specificity of 18F-DTBZ PET to the differential diagnosis of Parkinson's disease (PD) and other parkinsonism disorders, including multiple system atrophy (MSA), corticobasal degeneration (CBD), and progressive supranuclear palsy (PSP).
Timeline
- Start
- 2010-08
- Primary completion
- 2013-07
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 18F-FDG | Diagnostic / imaging agent | 370 mbq | Intravenous |